RAYMOND JAMES & ASSOCIATES - KINTARA THERAPEUTICS INC ownership

KINTARA THERAPEUTICS INC's ticker is KTRA and the CUSIP is 49720K101. A total of 26 filers reported holding KINTARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of KINTARA THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$6,000
-25.0%
15,7400.0%0.00%
Q4 2021$8,000
-42.9%
15,7400.0%0.00%
Q3 2021$14,000
-61.1%
15,7400.0%0.00%
Q2 2021$36,000
+33.3%
15,7400.0%0.00%
Q1 2021$27,00015,7400.00%
Other shareholders
KINTARA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
swisspartners Ltd. 275,000$624,0000.44%
Golden State Equity Partners 71,320$162,0000.06%
Nantahala Capital Management 523,279$1,188,0000.03%
Virtu Financial LLC 54,728$124,0000.01%
Allegiant Private Advisors, LLC 17,942$41,0000.01%
BREWIN DOLPHIN LTD 37,665$85,5000.00%
EVERGREEN CAPITAL MANAGEMENT LLC 24,837$56,0000.00%
Lindbrook Capital, LLC 5,135$12,0000.00%
Wealth Quarterback LLC 2,000$5,0000.00%
PURA VIDA INVESTMENTS, LLC 28,180$64,0000.00%
View complete list of KINTARA THERAPEUTICS INC shareholders